Related Experiment Videos
Steroid receptor content in cytosol from normal and hyperplastic human prostates
The Journal of Clinical Endocrinology and Metabolism
|August 1, 1979
Summary
Benign prostatic hyperplasia (BPH) tissue contains androgen and progestin receptors, but lacks estrogen and glucocorticoid receptors. Androgen receptors are more stable than progestin receptors in BPH tissue.
Area of Science:
- Endocrinology
- Urology
- Molecular Biology
Background:
- Steroid hormone receptors play critical roles in the development and function of the prostate.
- Benign prostatic hyperplasia (BPH) is a common condition in aging men, characterized by prostate enlargement.
- Understanding the presence and characteristics of steroid hormone receptors in BPH is crucial for potential therapeutic targets.
Purpose of the Study:
- To analyze and quantify steroid hormone receptor levels in benign prostatic hyperplasia (BPH) tissue.
- To compare receptor profiles between BPH and normal prostate tissues.
- To investigate the stability of identified receptors.
Main Methods:
- Cytosolic preparations from 40 BPH and 10 normal human prostates were analyzed.
- Dextran-coated charcoal technique was employed to measure steroid hormone receptor binding.
- Scatchard analysis was used to calculate binding data, including maximum binding sites and dissociation constants (Kd).
Main Results:
- All BPH specimens exhibited androgen receptors (methyltrienolone, MT) and most (25/28) contained progestin receptors (R5020).
- No estrogen or glucocorticoid receptors were detected in BPH specimens.
- Androgen receptors were present in all normal prostates, while progestin receptors were absent in 5/10. Estrogen receptors were found in 3/10 normal prostates; glucocorticoid receptors were absent.
Conclusions:
- BPH tissue is characterized by the presence of androgen and progestin receptors, with androgen receptors showing higher stability.
- The absence of estrogen and glucocorticoid receptors in BPH suggests specific roles for androgens and progestins in the condition.
- Ligand specificity confirms distinct androgen and progestin receptor populations in prostate tissue.